Durvalumab 相關新聞

Durvalumab 目前有 1 則相關新聞報導，預測適應症 10 個。

本頁整合 Durvalumab 的 AI 預測適應症與最新健康新聞，橘色標示的適應症表示近期有相關新聞報導。

藥物資訊

原適應症: 非小細胞肺癌、小細胞肺癌、膽道癌、肝細胞癌、子宮內膜癌、膀胱癌
證據等級: L3
預測適應症（10 個）:
- prostatic urethra urothelial carcinoma (100.0%)
- kidney pelvis sarcomatoid transitional cell carcinoma (100.0%)
- infiltrating bladder urothelial carcinoma sarcomatoid variant (100.0%)
- renal pelvis papillary urothelial carcinoma (100.0%)
- uterine ligament adenocarcinoma (99.9%)
- endocervical carcinoma (99.9%)
- adenoid cystic carcinoma of the cervix uteri (99.9%)
- uterine ligament serous adenocarcinoma (99.9%)
- signet ring cell variant cervical mucinous adenocarcinoma (99.9%)
- intestinal variant cervical mucinous adenocarcinoma (99.9%)

相關新聞（1 則）